2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 396.422 | 396.709 | 346.257 | 385.594 | 384.003 | 396.268 | 332.348 | 399.797 | 562.759 | 546.326 |
Total Income - EUR | 400.048 | 412.022 | 361.314 | 386.006 | 389.347 | 416.326 | 343.339 | 399.937 | 564.296 | 549.757 |
Total Expenses - EUR | 384.702 | 410.293 | 354.490 | 366.004 | 376.569 | 405.983 | 327.812 | 380.559 | 527.983 | 533.376 |
Gross Profit/Loss - EUR | 15.346 | 1.728 | 6.824 | 20.002 | 12.777 | 10.343 | 15.527 | 19.378 | 36.313 | 16.382 |
Net Profit/Loss - EUR | 11.703 | 544 | 4.811 | 8.832 | 8.882 | 6.354 | 12.325 | 15.490 | 30.793 | 12.453 |
Employees | 6 | 7 | 5 | 0 | 5 | 5 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Gero Tissue Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 30.217 | 23.488 | 36.734 | 26.152 | 24.812 | 14.339 | 46.476 | 76.503 | 220.791 | 332.999 |
Current Assets | 88.486 | 72.353 | 108.083 | 112.822 | 131.041 | 112.320 | 116.175 | 134.816 | 167.367 | 150.774 |
Inventories | 17.996 | 36.004 | 33.877 | 32.915 | 40.333 | 33.203 | 33.905 | 52.552 | 59.098 | 71.728 |
Receivables | 67.861 | 50.927 | 68.846 | 74.887 | 81.718 | 70.852 | 71.333 | 87.748 | 121.285 | 82.919 |
Cash | 2.630 | -14.577 | 5.361 | 5.020 | 8.990 | 8.265 | 10.936 | -5.484 | -13.015 | -3.873 |
Shareholders Funds | 12.239 | 1.084 | 5.885 | 9.357 | 9.398 | 6.860 | 12.822 | 15.975 | 31.280 | 28.220 |
Social Capital | 446 | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 |
Debts | 106.464 | 94.757 | 138.933 | 129.616 | 146.455 | 119.799 | 150.067 | 195.730 | 357.341 | 457.321 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4644 - 4644" | |||||||||
CAEN Financial Year |
1722
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Gero Tissue Srl